Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $5.06 (195.91% upside)

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/7/2014Cantor FitzgeraldDowngradeBuy -> Hold$2.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2014Roth CapitalDowngradeBuy -> Neutral$15.00 -> $1.30ViewTweet This Rating  Share This Rating on StockTwits
10/6/2014RBC CapitalDowngradeOutperform -> Sector Perform$9.00 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
10/6/2014WedbushReiterated RatingNeutral$10.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
10/6/2014Wells Fargo & Co.DowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
8/29/2014WedbushDowngradeOutperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
5/9/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/10/2014Cantor FitzgeraldBoost Price Target$8.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014Leerink SwannBoost Price TargetOutperform$14.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2014Leerink SwannBoost Price Target$10.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2013Credit SuisseDowngradeNeutralViewTweet This Rating  Share This Rating on StockTwits
1/15/2013Credit SuisseInitiated CoverageOutperform$7.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2012Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss Sunesis Pharmaceuticals